Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
bioRxiv (2022) - Comments
doi: 10.1101/2022.01.28.22270043 

Karin Hardt, An Vandebosch, Jerry Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, Javier Ruiz-Guiñazú, Saul N. Faust, Christoph D. Spinner, Hanneke Schuitemaker, Johan Van Hoof, Macaya Douoguih, Frank Struyf